Could a drug designed for weight loss help athletes perform better?
GLP-1 weight-loss drugs can reduce weight and improve health, but could they also boost athletic performance? Scientists say the evidence is unclear, but there is a growing debate around whether they could be considered performance enhancing.
TL;DR
- GLP-1 weight-loss drugs mimic gut hormones to reduce appetite and cause weight loss.
- Their potential to enhance athletic performance is under debate, with scientists noting unclear evidence.
- These drugs are not currently banned in professional sports but are on the World Anti-Doping Agency's (Wada) monitoring list.
- GLP-1s may offer health benefits beyond weight loss, such as reduced inflammation and improved cardiovascular health, though their mechanisms are not fully understood.
- In sports with strict weight categories, these drugs could be considered performance-enhancing, similar to banned diuretics.
- Potential side effects include muscle loss and gastrointestinal issues, which could negatively impact athletic performance.
- The drugs can suppress appetite, potentially leading to under-fuelling and hindering recovery and performance in athletes with high energy demands.
- Ethical concerns arise regarding the use of these drugs by athletes who do not have weight-related medical conditions, and their easy accessibility online.
- Celebrity endorsements and public advocacy are normalizing these drugs as lifestyle products, raising concerns about their use by teenagers and healthy individuals.
- Further research is needed to determine the actual effects of GLP-1s on athletic performance, with current data being insufficient to classify them as doping.